The use of Valtrex once a day lowers transmission of herpes
It is difficult to get rid of herpes completely but antiviral drugs help reduce the manifestation of symptoms, ease the course of the disease and drive the infection into a latent (dormant) form. This is no small matter since those who have already experienced this disease know that it gives a lot of trouble and inconvenience. Moreover, most of the varieties of the virus are very “contagious” and therefore the inner circle is also in danger. Valtrex is one of the drugs that help fight various forms of this disease.
A recent study has shown that the daily therapy with Valtrex decreases the risk of spreading genital herpes in couples in which one of the partners has an HSV-2 infection. The risk of transmitting the virus to heterosexual partners is reduced by about 50% in people infected with herpes who took a Valtrex pill once a day.
The study involved 1,484 heterosexual couples in which one partner was infected and another was not. The randomly chosen infected partners took either Valtrex 500 mg or a placebo once a day for 8 months.
Results of the daily therapy with Valtrex 500 mg demonstrated a significant decrease in the virus transmission risks
Studies have shown that antiviral therapy with Valtrex 500 mg once a day is able to significantly reduce the transmission of symptomatic genital herpes (by 75%) and the overall HSV-2 infection transmission (by 50%) in heterosexual couples. People who are concerned about the possible genital herpes transmission can use suppressive therapy with Valtrex to prevent transmission of the virus. Based on this study, to prevent transmission of genital herpes, it is recommended that doctors routinely propose heterosexual monogamous serologically discordant HSV-2 pairs to take Valtrex 500 mg once a day, along with recommendations for safe sexual behavior, including the use of condoms.
Benefits of daily therapy with Valtrex:
- fast effect of destructing viruses;
- multiple reductions of pain symptoms;
- there are practically no relapses after treatment;
- a rarity of adverse side effects;
- it has a longer action than Acyclovir pills.
In addition, it was revealed in the research that there was evidence of HSV-2 DNA found in genital secretions samples on 2.9% of the days in infected heterosexual partners who took daily therapy with Valtrex compared with 10.8% of the days in people who took the placebo. Daily therapy also lowered the recurrences of genital herpes among the infected partners.
Results provide a background for future HIV studies
The results may serve as the basis for future studies on preventing HSV-2 infection and reducing the HIV transmission risk by means of the daily antiviral therapy. Valtrex could help millions if the use of this antiviral drug is proven to reduce the HIV transmission by preventing HSV-2 genital sores.
Valtrex refers to the last generation antiherpetic drugs and provides the shortest and most convenient treatment for today. Valtrex is a special form of acyclovir and creates concentrations which are unattainable after taking even the highest doses of acyclovir.